These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35201266)

  • 21. Inhibition by KMI-574 leads to dislocalization of BACE1 from lipid rafts.
    Ebina M; Futai E; Tanabe C; Sasagawa N; Kiso Y; Ishiura S
    J Neurosci Res; 2009 Feb; 87(2):360-8. PubMed ID: 18798280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts.
    Cheng H; Vetrivel KS; Gong P; Meckler X; Parent A; Thinakaran G
    Nat Clin Pract Neurol; 2007 Jul; 3(7):374-82. PubMed ID: 17611486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid.
    Chen Y; Huang X; Zhang YW; Rockenstein E; Bu G; Golde TE; Masliah E; Xu H
    J Neurosci; 2012 Aug; 32(33):11390-5. PubMed ID: 22895721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.
    Sachse CC; Kim YH; Agsten M; Huth T; Alzheimer C; Kovacs DM; Kim DY
    FASEB J; 2013 Jun; 27(6):2458-67. PubMed ID: 23504710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation.
    Dias IH; Mistry J; Fell S; Reis A; Spickett CM; Polidori MC; Lip GY; Griffiths HR
    Free Radic Biol Med; 2014 Oct; 75():48-59. PubMed ID: 25048970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
    Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
    Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.
    Shah H; Patel A; Parikh V; Nagani A; Bhimani B; Shah U; Bambharoliya T
    CNS Neurol Disord Drug Targets; 2020; 19(3):184-194. PubMed ID: 32452328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compartmentalization of phosphatidylinositol 4,5-bisphosphate metabolism into plasma membrane liquid-ordered/raft domains.
    Myeong J; Park CG; Suh BC; Hille B
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BACE1 in Alzheimer's disease.
    Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
    Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses.
    Hartmann S; Zheng F; Kyncl MC; Karch S; Voelkl K; Zott B; D'Avanzo C; Lomoio S; Tesco G; Kim DY; Alzheimer C; Huth T
    J Neurosci; 2018 Apr; 38(14):3480-3494. PubMed ID: 29507146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane rafts in Alzheimer's disease beta-amyloid production.
    Vetrivel KS; Thinakaran G
    Biochim Biophys Acta; 2010 Aug; 1801(8):860-7. PubMed ID: 20303415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
    Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
    J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C99 domain of the amyloid precursor protein resides in the disordered membrane phase.
    Capone R; Tiwari A; Hadziselimovic A; Peskova Y; Hutchison JM; Sanders CR; Kenworthy AK
    J Biol Chem; 2021; 296():100652. PubMed ID: 33839158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptor protein 2-mediated endocytosis of the β-secretase BACE1 is dispensable for amyloid precursor protein processing.
    Prabhu Y; Burgos PV; Schindler C; Farías GG; Magadán JG; Bonifacino JS
    Mol Biol Cell; 2012 Jun; 23(12):2339-51. PubMed ID: 22553349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.
    Barão S; Moechars D; Lichtenthaler SF; De Strooper B
    Trends Neurosci; 2016 Mar; 39(3):158-169. PubMed ID: 26833257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.